Among the fund’s top holdings are Nestle (17.1%), Roche Holding Ltd. (13.1%), Novartis (10.9%).
The Swiss franc has been performing strongly against the U.S. dollar, as well:
Among the fund’s top holdings are Nestle (17.1%), Roche Holding Ltd. (13.1%), Novartis (10.9%).
The Swiss franc has been performing strongly against the U.S. dollar, as well: